HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoben Pan Selected Research

Oral Administration

1/2011Combination of α-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoben Pan Research Topics

Disease

4Infections
10/2023 - 01/2011
2Chronic Hepatitis C
01/2013 - 03/2011
1Pneumonia (Pneumonitis)
10/2023
1Non-alcoholic Fatty Liver Disease
03/2023
1Fibrosis (Cirrhosis)
03/2023
1Liver Cirrhosis (Hepatic Cirrhosis)
03/2023
1Hepatocellular Carcinoma (Hepatoma)
11/2019
1Viremia
01/2011
1Hepatitis B
06/2010

Drug/Important Bio-Agent (IBA)

2Antiviral Agents (Antivirals)IBA
03/2011 - 01/2011
2GlucosidasesIBA
03/2011 - 01/2011
1entecavirFDA Link
10/2023
1nasIBA
10/2023
1Tenofovir (Viread)FDA Link
10/2023
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
03/2023
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
11/2019
1Glycoproteins (Glycoprotein)IBA
01/2013
1Peptides (Polypeptides)IBA
01/2013
1Monoclonal AntibodiesIBA
01/2013
1Ribavirin (Virazole)FDA LinkGeneric
01/2011
1SugarsIBA
01/2011
1Imino SugarsIBA
01/2011
1Proteins (Proteins, Gene)FDA Link
06/2010

Therapy/Procedure

2Therapeutics
10/2023 - 01/2011
1Oral Administration
01/2011